Zach Sweeney
Profile
Currently, Zach Sweeney occupies the position of Chief Scientific Officer of Denali Therapeutics, Inc. Dr. Sweeney received an undergraduate degree from Stanford University.
Former positions of Zach Sweeney
| Companies | Position | End |
|---|---|---|
| DENALI THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 2019-12-31 |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Director/Board Member | - |
Training of Zach Sweeney
| Stanford University | Undergraduate Degree |
Experiences
Positions held
Linked companies
| Listed companies | 1 |
|---|---|
| DENALI THERAPEUTICS INC. | Health Technology |
| Private companies | 1 |
|---|---|
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Commercial Services |
- Stock Market
- Insiders
- Zach Sweeney
